Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Tumor microenvironment communication influences cancer progression.
• Cancer stem cells (CSCs) are crucial for tumor growth and recurrence.
• Phospholipid metabolism plays a role in cellular signaling.

Purpose of the Study:

• To investigate the role of phospholipase D2 (PLD2) in colon cancer.
• To elucidate the mechanism by which PLD2 affects the tumor microenvironment and CSCs.
• To identify potential therapeutic targets in colon cancer.

Main Methods:

• Analysis of PLD2 expression in colon tumors.
• In vitro studies on cancer cell-microenvironment interactions.
• In vivo mouse models to assess tumorigenesis and stemness.
• Analysis of senescence-associated secretory phenotype (SASP) factors and Wnt pathway activation.

Main Results:

• PLD2 is overexpressed and secreted by colon cancer cells.
• Secreted PLD2 induces fibroblast senescence via its lipase domain and phosphatidic acid production.
• Senescence promotes a SASP that enhances CSC stemness through Wnt pathway activation.
• PLD2 overexpression correlates with increased stemness, tumorigenesis in vivo, and Wnt pathway activation in human colon cancer patients.

Conclusions:

• Tumor cell-secreted PLD2 drives colon cancer development by reprogramming the microenvironment.
• PLD2-induced senescence and subsequent SASP create a feedback loop that increases CSCs.
• PLD2 is a potential therapeutic target for colon cancer, and its mechanism explains Wnt pathway activation in this disease.